CD4 and neoplasm: Similarly, PD-1, a negative regulator of adaptive anti-tumor immunity (30, 31), was increased in lymph node and splenic CD8+ T cells and splenic CD4+ of metastatic Stat4−/− mice compared to tumor bearing WT mice (Figures 2F,G).